Abstract
Objectives
Potentially inappropriate medications (PIM), especially those with potential effects on the central nervous system, can increase the risk of cognitive impairment. We investigated the association of the use of PIM and PIM that may impair cognition (PIM-Cog) with cognitive performance among older adults.
Methods
In this cross-sectional study with 2,626 participants, PIM and PIM-Cog were defined by the 2019 American Geriatrics Society Beers criteria. We calculated global cognition and memory, verbal fluency, and Trail Making Test B version (TMT-B) z-scores. Linear regression models adjusted for sociodemographic and clinical variables were used to investigate the association between PIM and cognition.
Results
27% and 7% of the sample (mean age = 65.1 ± 4.1 years old, 54% women, and 61% White) used at least one PIM and PIM-cog, respectively. PIM was associated with poor performance in the TMT-B (β = -0.17, 95% Cl = -0.29; -0.05, p = 0.007). PIM-Cog was also associated with poor TMT-B performance (β = -0.08, 95% Cl = -0.15; -0.01, p = 0.025).
Conclusion
The use of PIM and PIM-Cog was associated with poor executive function among older adults. The review of PIM use and the deprescription of these drugs may be an effective way to improve cognitive function.
Similar content being viewed by others
Availability of data and materials
Not applicable.
Change history
24 May 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00228-023-03512-5
References
Fick DM et al (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 67(4):674–694. https://doi.org/10.1111/jgs.15767
Oliveira MG, Amorim WW, Oliveira CRB, Coqueiro HL, Gusmão LC, Passos LC (2017) Consenso brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging 10(4):168–181. https://doi.org/10.5327/z2447-211520161600054
Borja-Oliveira CR, Assato CP (2015) Psicofármacos Potencialmente Inapropriados Para Idosos. Estud Interdiscip sobre o Envelhec 20(3). https://doi.org/10.22456/2316-2171.38548
dos Santos ANM, Nogueira DRC, de Borja-Oliveira CR (2018) Self-medication among participants of an Open University of the Third Age and associated factors. Rev Bras Geriatr e Gerontol 21(4):419–427. https://doi.org/10.1590/1981-22562018021.170204
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents. Arch Intern Med 151(9):1825–1832. https://doi.org/10.1001/archinte.1991.00400090107019
Samuel MJ (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246. https://doi.org/10.1111/jgs.13702
Berryman SN, Jennings J, Ragsdale S, Lofton T, Huff DC, Rooker JS (2012) Beers criteria for potentially inappropriate medication use in older adults. Medsurg Nurs 21(3)
Santos AN, Nogueira DR, Gutierrez BA, Chubaci RY, Oliveira CR (2020) Cardiometabolic diseases and active aging - polypharmacy in control. Rev Bras Enferm 73(2):e20180324. https://doi.org/10.1590/0034-7167-2018-0324
Borja-Oliveira CR (2017) Efeitos da carga anticolinérgica cognitiva em idosos – uma revisão integrativa. Estudos Interdisciplinares sobre o Envelhecimento 22(2):57–74. https://doi.org/10.22456/2316-2171.60273
Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 89(1):73–120. https://doi.org/10.1152/physrev.00015.2008
Ventura ALM, Abreu PA, Freitas RCC, Sathler PC, Loureiro N, Castro HC (2010) Colinergic system: Revisiting receptors, regulation and the relationship with Alzheimer disease, schizophrenia, epilepsy and smoking. Arch Clin Psychiatry 37(2):66–72. https://doi.org/10.1590/S0101-60832010000200007
Caçador C, Teixeira-Lemos E, Oliveira J, Pinheiro J, Teixeira-Lemos L, Ramos F (2022) The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study. Int J Environ Res Public Health 19(5). https://doi.org/10.3390/ijerph19052637
Krüger C (2021) Comparison of FORTA, PRISCUS and EU(7)-PIM lists on identifying potentially inappropriate medication and its impact on cognitive function in multimorbid elderly German people in primary care: A multicentre observational study. BMJ Open 11(9). https://doi.org/10.1136/bmjopen-2021-050344
Aquino EML et al (2012) Brazilian Longitudinal Study of Adult health (ELSA-Brasil): Objectives and design. Am J Epidemiol 175(4):315–324. https://doi.org/10.1093/aje/kwr294
Passos VM, Ladeira RM, Souza CC, Santos ID, Barreto SM (2018) First stages chronic kidney disease have mild effects on cognitive performance. Results of a 15,105 brazilian adult baseline cohort. J Bras Nefrol 40(1):18–25. https://doi.org/10.1590/1678-4685-JBN-3889
Chor D et al (2013) Questionario do ELSA-Brasil: desafios na elaboracao de instrumento multidimensional. Rev Saude Publica 47(suppl 2):27–36. https://doi.org/10.1590/s0034-8910.2013047003835
Schmidt MI et al (2015) Cohort profile: Longitudinal study of adult health (ELSA-Brasil). Int J Epidemiol 44(1):68–75. https://doi.org/10.1093/ije/dyu027
Passos VM, Caramelli P, Benseñor I, Giatti L, Barreto SM (2014) Métodos de investigação da função cognitiva no estudo longitudinal de Saúde do Adulto (ELSA-Brasil). Sao Paulo Med J 132(3):170–177. https://doi.org/10.1590/1516-3180.2014.1323646
Akiyama H (2011) CERAD (The Consortium to Establish a Registry for Alzheimer’s Disease) criteria. Nihon Rinsho 69(Suppl 1, no. Pt 2):264–269
Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR (2001) Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 59(3A):532–536. https://doi.org/10.1590/s0004-282x2001000400009
Nunes MA, Alves MD, Chor D, Schmidt MI, Duncan BB (2011) Cross-cultural adaptation of CIS-R (Clinical Interview Schedule-Revised Version) for the portuguese in Longitudinal Study Of Adult Health (ELSA). Hcpa 31(4):487–490. [Online]. Available: http://seer.ufrgs.br/hcpa488
Pitanga FJ, Matos S, Almeida MD, Barreto SM, Aquino EM (2018) Leisure-time physical activity, but not commuting physical activity, is associated with cardiovascular risk among ELSA-Brasil participants. Arq Bras Cardiol 110(1):36–43. https://doi.org/10.5935/abc.20170178
Sönnerstam E, Sjölander M, Gustafsson M (2017) An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol 73(6):735–742. https://doi.org/10.1007/s00228-017-2218-2
Maclagan LC et al (2017) Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition. J Am Geriatr Soc 65(10):2205–2212. https://doi.org/10.1111/jgs.15016
Stuss DT, Levine B (2002) Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annu Rev Psychol 53(February 2002):401–433. https://doi.org/10.1146/annurev.psych.53.100901.135220
Mattay VS, Goldberg TE, Sambataro F, Weinberger DR (2008) Neurobiology of cognitive aging: Insights from imaging genetics. Biol Psychol 79(1):9–22. https://doi.org/10.1016/j.biopsycho.2008.03.015
Richardson K et al (2018) Anticholinergic drugs and risk of dementia: Case-control study. BMJ 361:1–12. https://doi.org/10.1136/bmj.k1315
Connor MNO, Gallagher P, Mahony DO (2002) Inappropriate prescribing. N Z Med J 115(1146):28. https://doi.org/10.2165/11632610-000000000-00000
Hafdi M, Hoevenaar-Blom MP, Beishuizen CRL, Moll van Charante EP, Richard E, van Gool WA (2020) Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults. J Am Med Dir Assoc 21(2):188-193.e3. https://doi.org/10.1016/j.jamda.2019.05.010
Chuang YF, Elango P, Gonzalez CE, Thambisetty M (2017) Midlife anticholinergic drug use, risk of Alzheimer’s disease, and brain atrophy in community-dwelling older adults. Alzheimer’s Dement Transl Res Clin Interv 3(3):471–479. https://doi.org/10.1016/j.trci.2017.06.004
Cai X, Campbell N, Khan B, Callahan C, Boustani M (2013) Long-term anticholinergic use and the aging brain. Alzheimer’s Dement 9(4):377–385. https://doi.org/10.1016/j.jalz.2012.02.005
Iyer S et al (2020) Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study. Int Urogynecol J 31(12):2653–2660. https://doi.org/10.1007/s00192-019-04140-3
Zelazo PD, Craik FIM, Booth L (2004) Executive function across the life span. Acta Psychol (Amst) 115(2–3):167–183. https://doi.org/10.1016/j.actpsy.2003.12.005
Acknowledgements
The ELSA-Brasil study was supported by the Brazilian Ministry of Health and the CNPq (grants 01060010.00RS, 01060212.00BA, 01060300.00ES, 01060278.00MG, 01060115.00SP, 01060071.00RJ). DSF-I received a scholarship from São Paulo Research Foundation (FAPESP) (2017/24066-1).
Author information
Authors and Affiliations
Contributions
ANMS: design, statistical analysis, and manuscript draft. DSF-I: statistical analysis, critical revision of the manuscript, and approval of the final manuscript version. IMB: funding, critical revision of the manuscript, and approval of the final manuscript version. ACG: critical revision of the manuscript, and approval of the final manuscript version. ARB: critical revision of the manuscript, and approval of the final manuscript version. MCV: funding, critical revision of the manuscript, and approval of the final manuscript version. PAL: funding, critical revision of the manuscript, and approval of the final manuscript version. CKS: design, statistical analysis, supervision, and manuscript draft.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Competing interests
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The manuscript has not been submitted or published elsewhere.
The original online version of this article was revised: The correct family name of the 2nd Author is Itao not Iao.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
dos Santos, A.N.M., Farias-Itao, D.S., Benseñor, I.M. et al. Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA–Brasil study. Eur J Clin Pharmacol 79, 927–934 (2023). https://doi.org/10.1007/s00228-023-03504-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-023-03504-5